热门资讯> 正文
Optinose GAAP每股收益-0.12美元，收入1，488万美元
2024-05-14 19:25
- Optinose press release (NASDAQ:OPTN): Q1 GAAP EPS of -$0.12.
- The Company reported $14.9 million in net revenue from sales of XHANCE during the three-month period ended March 31, 2024, an increase of 26% compared to $11.8 million during the three-month period ended March 31, 2023.
More on OptiNose
- OptiNose, Inc. 2023 Q4 - Results - Earnings Call Presentation
- OptiNose, Inc. (OPTN) Q4 2023 Earnings Call Transcript
- OptiNose granted FDA nod to expand labeling for sinusitis therapy
- Seeking Alpha’s Quant Rating on OptiNose
- Historical earnings data for OptiNose
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
